Literature DB >> 25785523

Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.

Kevin E Vowles1, Mindy L McEntee, Peter Siyahhan Julnes, Tessa Frohe, John P Ney, David N van der Goes.   

Abstract

Opioid use in chronic pain treatment is complex, as patients may derive both benefit and harm. Identification of individuals currently using opioids in a problematic way is important given the substantial recent increases in prescription rates and consequent increases in morbidity and mortality. The present review provides updated and expanded information regarding rates of problematic opioid use in chronic pain. Because previous reviews have indicated substantial variability in this literature, several steps were taken to enhance precision and utility. First, problematic use was coded using explicitly defined terms, referring to different patterns of use (ie, misuse, abuse, and addiction). Second, average prevalence rates were calculated and weighted by sample size and study quality. Third, the influence of differences in study methodology was examined. In total, data from 38 studies were included. Rates of problematic use were quite broad, ranging from <1% to 81% across studies. Across most calculations, rates of misuse averaged between 21% and 29% (range, 95% confidence interval [CI]: 13%-38%). Rates of addiction averaged between 8% and 12% (range, 95% CI: 3%-17%). Abuse was reported in only a single study. Only 1 difference emerged when study methods were examined, where rates of addiction were lower in studies that identified prevalence assessment as a primary, rather than secondary, objective. Although significant variability remains in this literature, this review provides guidance regarding possible average rates of opioid misuse and addiction and also highlights areas in need of further clarification.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25785523     DOI: 10.1097/01.j.pain.0000460357.01998.f1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  280 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

2.  Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation.

Authors:  Andrew H Rogers; Michael F Orr; Justin M Shepherd; Jafar Bakhshaie; Joseph W Ditre; Julia D Buckner; Michael J Zvolensky
Journal:  J Behav Med       Date:  2020-06-27

3.  Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study.

Authors:  Claire Lattard; Catherine Chenailler; Annaelle Soubieux; Andre Gillibert; Henri Gondé; Marie Kozyreff-Meurice; Sophie Pouplin; Thierry Lequerré; Rémi Varin; Olivier Vittecoq
Journal:  Clin Rheumatol       Date:  2021-05-25       Impact factor: 2.980

4.  Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial.

Authors:  Kevin E Vowles; Katie Witkiewitz; Karen J Cusack; Wesley P Gilliam; Karen E Cardon; Sarah Bowen; Karlyn A Edwards; Mindy L McEntee; Robert W Bailey
Journal:  J Pain       Date:  2019-11-21       Impact factor: 5.820

Review 5.  Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Authors:  Katie Witkiewitz; Kevin E Vowles
Journal:  Alcohol Clin Exp Res       Date:  2018-02-06       Impact factor: 3.455

6.  [Interdisciplinary pain assessment in the hospital setting : Merely a door-opener to multimodal pain therapy?]

Authors:  E Sens; M Mothes-Lasch; J F Lutz
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

Review 7.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.

Authors:  Charl Els; Tanya D Jackson; Diane Kunyk; Vernon G Lappi; Barend Sonnenberg; Reidar Hagtvedt; Sangita Sharma; Fariba Kolahdooz; Sebastian Straube
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

Review 8.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

9.  μ-Opioid Receptor Agonists: Do They Have Utility in the Treatment of Acute Pain?

Authors:  Thomas K Henthorn; Susan K Mikulich-Gilbertson
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

Review 10.  Clinical Use of Placebo Effects in Patients With Pain Disorders.

Authors:  Regine Klinger; Julia Stuhlreyer; Marie Schwartz; Julia Schmitz; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.